CBD and THC - Meet Your New Neighbors
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
CBD and THC – Meet Your New Neighbors Darrin Grondel Vice President, Government Relations and Traffic Safety – Responsibility.org / National Alliance to Stop Impaired Driving Amy Miles Director of Forensic Toxicology, National Resource Toxicologist – WI State Lab of Hygiene, UW School of Medicine and Public Health 1
Session Objectives • Discuss the national perspective and rules around CBD, THC and isomers • Outline the toxicology of CBD, THC and isomers and adulterants • Explain Computerized Assessment and Referral System (CARS) to identify substance abuse and mental health issues 2
What do we know about Cannabis? 480 Chemical Compounds Cannabigerol CBG 66 – 113 cannabinoid compounds Cannabichromenes-CBC Delta 9 – THC (1964) Cannabinodial CBDL now Delta 8, 9, 10, 11,? Cannabicyclol CBL Cannabinol CBN (1899) Cannabielsoin CBE Cannabidiol CBD (1963) Cannabitriol CBT Cannabidivarin CBDV http://learnaboutmarijuanawa.org/factsheets/cannabinoids.htm https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/ 4
SIGNS AND SYMPTOMS of MJ IMPAIRMENT THC/CBD and similar compounds bind with receptors (CB1 and CB2) in the brain and other parts of the body affecting the function of the hippocampus (short- term memory), cerebellum (coordination) and basal ganglia (unconscious muscle movements). • Marijuana is a lipid (fat) soluble and tends to stay in the brain • Alcohol is water soluble - blood Reference - http://www.brainwaves.com/ 5
Hemp vs. Marijuana? • Morphological characteristics of the plant (macroscopic, microscopic, smell, etc.) are exactly the same. • A person cannot tell the difference by looking at or smelling the plant. • The only way to differentiate is through laboratory testing to determine THC concentration. • How does the user know what they are consuming – the packaging! https://www.endoca.com/ 7
Regulation of CBD • Is CBD legal in the U.S? Agricultural Improvement Act – the 2018 Farm Bill allows for CBD from Hemp – Sativa Plant • Federal - Food and Drug Administration has not approved CBD for any disease or condition • Exception - Epidiolex – Purified form of CBD – Seizures - Lennox-Gastaut syndrome or Dravet syndrome, and tuberous sclerosis complex. • Prescribed by a medical provider and medication guide due the impacts • The Federal Food, Drug and Cosmetic Act (FD&C) addresses unapproved products with product claims it treats, diagnosis, mitigates, treats or cures various diseases. • Is it legal in your State? Check your state laws as they differ (https://www.ncsl.org/research/health/state-medical-marijuana- laws.aspx) • Some states legalized for CBD products that are approved by the Food and Drug Administration (FDA), so is this a safeguard for the state? • Some include both FDA approval and
Regulation • Manufacturing process of CBD products has not been assessed by the FDA • “A regulatory standard for labeling accuracy of CBD does not exist” (Geoffrey et al, 2021) • No third-party regulatory process nationally or at state level to verify product ingredients, contaminants, or quality. • FDA sent out five warning letters in December of 2020 to companies who are illegally selling unapproved CBD products in violation of the FD&C. • Impaired Driving – the FDA found that CBD can cause sleepiness, sedation, and lethargy, based on their research with Epidiolex. Remember, if stopped and taking CBD products with THC concentrations, the THC could be detected. 9
Regulation – Labeling – Adulteration • Horth, R. Z. et al, Acute poisonings from a Synthetic Cannabinoid - Utah 2017- 2018 • Clear case of why we need regulation, accuracy in labeling and concerns of adulteration • 52 people identified • Branded as “YOLO CBD Oil” • “Nine product samples (including one unopened product purchased by investigators from a store and brand reported by a patient) were found to contain a synthetic cannabinoid, 4-cyano CUMYL-BUTINACA (4-CCB), but no CBD.” • Symptoms – altered mental state, nausea or vomiting, and seizures or shaking, anxiety, unconsciousness. • 73% vaped, 17% sublingual • 67% Recreational, 28.8% Medical, 10
Adulterations CBD products are not regulated and is subject to concerns about product labeling, contaminants, or adulterations… (Gurley et al., 2020) research on labeling consistency for cannabidiol (CBD) products examined 25 different commercial samples obtained in the state of Mississippi. •Only three were within 20% of claimed labeling •15 were well below stated claims •Two exceeded claims by more than 50% •Three exceeded the legal limit of 0.3% THC content •Four products marketed for vaping were contaminated with synthetic cannabinoids (potential for acute and chronic health effects) Gurley, B. J., Murphy, T. P., Gul, W., Walker, L. A., & ElSohly, M. (2020). Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi. Journal of Dietary Supplements, 17(5), 599–607. https://doi.org/10.1080/19390211.2020.1766634 11
THC Concentrations over the Years 1973 3% 2008 10% 2019 20% - Cannabis flower being sold in stores 30% 12
THC Potency Used In Most Government Studies addressing crash risk 13
Toxicology of THC, THC isomers and CBD 14
CANNABINOIDS • D9 most readily studied of all isomers • D8, D10 quickly becoming prolific as alternative to D9 with limited scientific data • CBD still available, reports of users turning to isomers • Active metabolite of D9 = 11-hydroxy-THC • Route of administration effects metabolite ration profile
Route of Administration • Oral • Edibles • Smoking • Vaping • Typical smoking • Concentrates • Oils • Waxes 16
Delta-9-THC (parent) Psychoactive component in THC Very short half life 11-Hydroxy-THC (metabolite) Equipotent to delta-9-THC at certain concentrations Very short half life Carboxy-THC (metabolite) *Only reported analyte for urine* No psychoactive impairment Longer half life 17
The Feel Good Factory 18
Contains 20% CBD Contains 10% CBD 19
Delta - 7 Delta - 8 THC Isomers Delta - 10 ? 20
Shutterstock 21
Consumer Products 22
Regulations? • No FDA oversight • “Tested” products are misleading • Common adulterants include synthetic cannabinoids 23
24
• Products contained an excess of 0.3% THC • Synthetic cannabinoids detected in products marketed for vaping • “From this small, but diverse, samples of hemp-derived merchandise, it appears that most product label claims do not accurately reflect actual CBD content and are fraudulent in that regard.” 25
Case Histories 26
Cannabis Impairment Detection Workshops 27
Cannabis Impairment Detection Workshop Handbook: o New publication from the National District Attorneys Association’s National Traffic Law Center and Responsibility.org o Provides answers on how to host and conduct Green Labs o Potential issues highlighted with solutions o Addresses LE hosted workshops and those conducted by contractors o Recently utilized by Maryland State Police for their police agency-hosted workshop https://www.responsibility.org/wp-content/uploads/2020/11/FAAR_4090-Cannabis-Impairment-Detection-Workshop-Handbook_V-3-002.pdf 28
HOW: Classroom curriculum: Potential topics- • Current products available • Ingestion methods and consideration of duration of effects • THC v. CBD • Different types of high (Indica/Sativa strains) • Polydrug use (cannabis and alcohol) • How cannabis impairs a driver • General indicators of impairment • SFSTs/ARIDE roadside tests and how they specifically point to cannabis impairment • Wrap up / critique
HOW: Lab/workshop curriculum Potential Topics- ❖General indicators of cannabis impairment ❖SFSTs/ARIDE roadside tests and how they specifically point to cannabis impairment o HGN expectations o Importance of ARIDE tests o Frequent users versus occasional users o Oral fluid as a screening device roadside tool o Q & A with consumers • Direct interaction with users in a controlled environment at optimal impairment time • Medic present
Enforcement (optional) o To be conducted directly following training (classroom & lab) o Saturation patrol and/or checkpoints o Events in the area (concerts, festivals) o Important dates (April 20th, July 10th) Montgomery County stats after first lab: • Total traffic stops:47 stops • Total traffic citations: 40 citations • Total traffic warnings: 47 warnings • Additional: • 1 DUID (DRE performed-determined to be under the influence of cannabis) • 1 DUI alcohol • 2 Civil citations for possession of marijuana under 10 grams • 1 PWID marijuana arrest ($1760.00 seized along with marijuana)
Computerized Assessment and Referral System (CARS) 32
High Risk Impaired Drivers Conviction Focused Approach Individualized Justice Approach Law enforcement trained only on alcohol Expanded DUID training (ARIDE, DRE, oral fluid) Test only for alcohol if per set limit reached Test for alcohol and drugs Multiple prosecutors handle a single DUI case Vertical prosecution Cases heard in criminal/civil courts DUI and treatment courts Inconsistent screening & assessment using generic tools Screening & assessment at multiple phases using tools validated specifically among the DUI population Emphasis on punishment (fines & jail) as prescribed in Investment in treatment and supervision determined by statute multidisciplinary team and informed by assessment Probation generalists Mental Health/SUD probation specialists Siloed data systems Linked impaired driving data system Leverage your State DUI Task Force or Impaired Driving Work Groups
High Risk and Repeat Offenders 34
Criminogenic Risk Factors History of Family/ Anti-social Leisure/ anti-social marital cognitions recreation behavior discord Anti-social Anti-social Substance School/ personality associates abuse work pattern 35
Mental Health? While not a criminogenic need, it is imperative that mental health issues be identified and treated to adequately address other risk factors. 36
Development of CARS • CARS was developed by a team of researchers from Cambridge Health Alliance, a teaching affiliate of Harvard Medical School. – Initial grant funding was provided by NIAAA; Responsibility.org continues to fund CARS research and implementation. • The goal was to create an assessment tool specifically for a DUI offender population that fills the mental health void that exists with traditional instruments. 37
38
What is CARS? Diagnostic report generator Mental Case Brief management health intervention assessment Referral database 39
What is CARS? • Diagnostic report generator that gives providers and clients: – Immediate diagnostic information for up to 20 DSM-V Axis I disorders (onset, recency, persistence). – Geographically and individually targeted referrals to treatment services based on the outcomes of the assessment. Substance dependence Intervention Mental health issues 40
CARS comprehensive mental health screener domains Panic disorder Social phobia Eating disorders Attention deficit/hyperactivity Obsessive compulsive Intermittent explosive disorder disorder disorder Depression Generalized anxiety Suicidality Mania/bipolar disorder Post-traumatic stress disorder Conduct disorder Oppositional defiant Psychosis Nicotine dependence disorder Alcohol use disorder Drug use disorder Gambling disorder Psychosocial stressors DUI/criminal behavior 41
How does CARS work? 42
How does CARS work? • Individual diagnostic reports have been programmed to provide information about the mental health disorders for which a person qualifies or is at risk, as well as a summary of bio-psycho-social risk factors. • The CARS tool includes a section on DUI behavior. – The data obtained from the questions in this section is integrated with other risk factors to generate an overall DUI recidivism risk score. – A graphic is generated as part of the outcomes report that indicates where an individual is within a range of low to very high risk. 43
CARS Report 44
CARS Report 45
Bridging the gap… • Unlike traditional assessments, CARS has a built-in referral system. • CARS has been designed to include a list of individually-targeted referrals at the end of each report based on an individual’s issues and zip code. • Before CARS can be implemented, the referral list must be populated with treatment services that are available within that jurisdiction. 46
Benefit of CARS • Provides immediate diagnostic information for up to 20 major psychiatric disorders. • Provides geographically and individually targeted referrals to appropriate treatment services. • Generates user-friendly reports at the click of a button. • Informs supervision and treatment decisions. • Runs on free open-source software. • Can be used by non-clinicians. • Applicable in a number of settings. 47
National Roll-Out CARS was launched for general use in June 2017. Available to any court, probation department, or program free of cost. Online web portal for downloads and training: www.carstrainingcenter.org 48
Contact Information Darrin T. Grondel Vice President – Government Relations and Traffic Safety Darrin.Grondel@Responsibility.org 571-309-7615 Amy Miles Director of Forensic Toxicology Wisconsin State Laboratory of Hygiene UW School of Medicine and Public Health Direct: 608-224-6247 amy.miles@slh.wisc.edu /GoFAAR @goFAAR @go_FAAR /faar /GoFAAR 49
You can also read